Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000189653 | SCV000243299 | uncertain significance | not provided | 2015-01-14 | criteria provided, single submitter | clinical testing | p.His433Tyr (CAT>TAT): c.1297 C>T in exon 10 of the SYN1 gene (NM_133499.2) A variant of unknown significance has been identified in the SYN1 gene. The H433Y missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. The H433Y variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. However, multiple in silico algorithms predict it is non-pathogenic. Therefore, based on the currently available information, it is unclear whether H433Y is a disease-causing mutation or a rare benign variant. The variant is found in CHILD-EPI, EPILEPSY panel(s). |
Invitae | RCV000558124 | SCV000639937 | benign | Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Neuro |
RCV000558124 | SCV000693799 | likely pathogenic | Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders | 2018-01-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000189653 | SCV001156016 | likely benign | not provided | 2018-10-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003927752 | SCV004740578 | likely benign | SYN1-related condition | 2022-02-22 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |